These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjögren's syndrome patients by use of a transfected cell line assay. Gao J, Cha S, Jonsson R, Opalko J, Peck AB. Arthritis Rheum; 2004 Aug; 50(8):2615-21. PubMed ID: 15334476 [Abstract] [Full Text] [Related]
3. The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjögren's syndrome: a critical review. Sumida T, Tsuboi H, Iizuka M, Hirota T, Asashima H, Matsumoto I. J Autoimmun; 2014 Jun; 51():44-50. PubMed ID: 24397962 [Abstract] [Full Text] [Related]
4. Functional role of M3 muscarinic acetylcholine receptor (M3R) reactive T cells and anti-M3R autoantibodies in patients with Sjögren's syndrome. Sumida T, Tsuboi H, Iizuka M, Nakamura Y, Matsumoto I. Autoimmun Rev; 2010 Jul; 9(9):615-7. PubMed ID: 20462524 [Abstract] [Full Text] [Related]
5. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome. Waterman SA, Gordon TP, Rischmueller M. Arthritis Rheum; 2000 Jul; 43(7):1647-54. PubMed ID: 10902771 [Abstract] [Full Text] [Related]
7. Fcgamma receptors mediate internalization of anti-Ro and anti-La autoantibodies from Sjögren's syndrome and apoptosis in human salivary gland cell line A-253. Lisi S, Sisto M, Soleti R, Saponaro C, Scagliusi P, D'Amore M, Saccia M, Maffione AB, Mitolo V. J Oral Pathol Med; 2007 Oct; 36(9):511-23. PubMed ID: 17850433 [Abstract] [Full Text] [Related]
11. Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Dawson LJ, Stanbury J, Venn N, Hasdimir B, Rogers SN, Smith PM. Arthritis Rheum; 2006 Apr; 54(4):1165-73. PubMed ID: 16572451 [Abstract] [Full Text] [Related]
12. Autoantibodies against a 72-kDa ductal cell membrane glycoprotein in a patient affected by Sjögren's syndrome and gastric MALT lymphoma. Folli F, Perego L, Ponzoni M, Girardi AM, Bosi E, Ferreri AJ, Bellone M, Sabbadini MG, Vicari AM, Trusolino L. Ann Hematol; 2002 Oct; 81(10):597-602. PubMed ID: 12424543 [Abstract] [Full Text] [Related]
14. Evidence that anti-muscarinic antibodies in Sjögren's syndrome recognise both M3R and M1R. Schegg V, Vogel M, Didichenko S, Stadler MB, Beleznay Z, Gadola S, Sengupta C, Stadler BM, Miescher SM. Biologicals; 2008 Jul; 36(4):213-22. PubMed ID: 18249005 [Abstract] [Full Text] [Related]
15. Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La. Pillemer SR, Casciola-Rosen L, Baum BJ, Rosen A, Gelber AC. J Rheumatol; 2004 Jun; 31(6):1121-5. PubMed ID: 15170924 [Abstract] [Full Text] [Related]
16. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjögren's syndrome. Matsumoto I, Tsubota K, Satake Y, Kita Y, Matsumura R, Murata H, Namekawa T, Nishioka K, Iwamoto I, Saitoh Y, Sumida T. J Clin Invest; 1996 Apr 15; 97(8):1969-77. PubMed ID: 8621782 [Abstract] [Full Text] [Related]
17. Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren syndrome. Bacman S, Berra A, Sterin-Borda L, Borda E. Invest Ophthalmol Vis Sci; 2001 Feb 15; 42(2):321-7. PubMed ID: 11157861 [Abstract] [Full Text] [Related]
20. Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren's syndrome-like sialoadenitis. Iizuka M, Wakamatsu E, Tsuboi H, Nakamura Y, Hayashi T, Matsui M, Goto D, Ito S, Matsumoto I, Sumida T. J Autoimmun; 2010 Dec 15; 35(4):383-9. PubMed ID: 20864316 [Abstract] [Full Text] [Related] Page: [Next] [New Search]